3
Announcements
Trials
Browse
Landscape
Status
Completed
4
Recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Gastrointestinal
1
Conditions
Lung Neoplasms
3
Prostatic Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Breast Neoplasms
2
Urinary Bladder Neoplasms
1
Small Cell Lung Carcinoma
1
Radiation Pneumonitis
1
Radiation Fibrosis Syndrome
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pelvic Neoplasms
1
Pancreatic Neoplasms
1
Multiple Myeloma
1
Malignant Solid Neoplasm
1
Malignant Primary Pelvic Neoplasm
1
Lymphoma, Non-Hodgkin
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Hodgkin Disease
1
Hematopoietic and Lymphatic System Neoplasm
1
Heart Defects, Congenital
1
Colorectal Neoplasms
1
Carcinoma, Transitional Cell
1
Anatomic Stage I Breast Cancer American Joint Committee on Cancer (AJCC) v8
1
Interventions
Bevacizumab
77
Fluorouracil
55
Cetuximab
48
Oxaliplatin
43
Leucovorin
42
pembrolizumab
37
Irinotecan
33
Folfox protocol
24
Capecitabine
24
HMPL-013
22
Specimen Handling
19
trifluridine tipiracil drug combination
17
Panitumumab
15
Blood Specimen Collection
15
Nivolumab
14
Magnetic Resonance Spectroscopy
14
regorafenib
13
Biopsy
13
Trifluridine
12
Gemcitabine
12
Cisplatin
12
Standard of Care
11
sintilimab
10
Interviews as Topic
10
IFL protocol
10
Drug Therapy
10
Carboplatin
10
Cyclophosphamide
9
tislelizumab
8
Trastuzumab
8
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Colorectal Neoplasms
×
Exercise Test
×
Clear all
NCT06073431
2026-01-09
LOTUS
University of Rochester
Recruiting
800 enrolled